Latest news with #EBSCO
Yahoo
10 hours ago
- Business
- Yahoo
See the Incredible Returns If You Invested in 10 of the Top Performing Stocks Over the Last 5 Years (Including GameStop)
Volatility is no fun if you're a stock market investor — and there's been plenty of that so far in 2025. But it's important to keep in mind that stocks in general have always produced strong returns over time. The S&P 500 has risen by about 91% over the past five years alone, despite major headwinds ranging from COVID-19 and soaring inflation to President Donald Trump's current tariff threats. The Dow is up about 62% over the same time frame, while the Nasdaq has roughly doubled in value. Discover More: Find Out: Those are all very good returns, but they pale in comparison to the best performing stocks. If you were fortunate enough to invest in one of those, you would have seen your money rise more than 10-fold in the last half-decade. One reason some of the best performers rose so fast is that they traded at very low values five years ago — in some cases around $1 a share. Any spike in value would represent a major percentage gain. An example is GameStop, the gaming and entertainment company whose stock could be purchased for a little more than $1 a share in June 2020. GameStop grabbed headlines in early 2021 when professional investors shorted the stock, figuring it would go down in value. But as EBSCO noted at the time, a 'wave' of amateur investors started buying up shares and helped the stock soar by more than 1,500% in a matter of weeks. Today, GameStop trades for around $30 a share. If you had invested $100 in the company in early June of 2020, your investment would now be worth more than $2,500. Here's a look at the massive returns you would have gotten by investing in 10 of the top performing stocks over the past five years. Each has risen by at least 1,000% and boasts a current price of roughly $30 a share or more. Trending Now: Closing price June 8, 2020: $3.10 per share Closing price June 4, 2020: $132.41 5-year return: 4,171% Closing price June 8, 2020: $1.25 Closing price June 4, 2020: $44.97 5-year return: 3,498% Closing price June 8, 2020: $11.80 Closing price June 4, 2020: $378.10 5-year return: 3,104% Closing price June 8, 2020: $1.18 Closing price June 4, 2020: $29.95 5-year return: 2,438% Closing price June 8, 2020: $3.97 Closing price June 4, 2020: $84.89 5-year return: 2,038% Closing price June 8, 2020: $10.51 Closing price June 4, 2020: $193.81 5-year return: 1,744% Closing price June 8, 2020: $6.57 Closing price June 4, 2020: $119.90 5-year return: 1,725% Closing price June 8, 2020: $5.35 Closing price June 4, 2020: $91.66 5-year return: 1,613% Closing price June 8, 2020: $2.71 Closing price June 4, 2020: $46.16 5-year return: 1,603% Closing price June 8, 2020: $10.37 Closing price June 4, 2020: $122.82 5-year return: 1,084% More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 8 Common Mistakes Retirees Make With Their Social Security Checks 10 Cars That Outlast the Average Vehicle This article originally appeared on See the Incredible Returns If You Invested in 10 of the Top Performing Stocks Over the Last 5 Years (Including GameStop)
Yahoo
03-04-2025
- Business
- Yahoo
EBSCO Clinical Decisions Dyna AI Now Available for DynaMedex® Individual Subscribers
~ Empowering Clinicians with Personalized, AI-Powered, Clinical Decision Support ~ IPSWICH, Mass., April 3, 2025 /PRNewswire-PRWeb/ -- EBSCO Clinical Decisions is pleased to announce the availability of Dyna AI for individual subscribers of DynaMedex®. Leveraging generative artificial intelligence, Dyna AI delivers evidence-based information to clinicians at the point of care with unprecedented speed and accuracy, now accessible without an institutional subscription. Available on any device, Dyna AI ensures clinicians receive reliable and trusted answers whenever and wherever they need them. Initially launched in July 2024, the mobile capability was introduced in October 2024. EBSCO Clinical Decisions is at the forefront of transforming clinical decision-making, addressing the growing demand for rapid access to high-quality clinical information. By responsibly deploying generative AI, EBSCO Clinical Decisions addresses modern challenges like cognitive overload and clinician burnout. Dyna AI revolutionizes the industry by offering concise, actionable clinical answers with clear citations of expert-curated, evidence-based information exclusively available from EBSCO Clinical Decisions. Tailored to meet the needs of today's clinicians, Dyna AI for DynaMedex provides a personalized approach, empowering users to swiftly access the most accurate and relevant information wherever and however they need. This update allows individual clinicians to access trusted DynaMedex information at AI speed, without an institutional subscription. Julia Colpitts, Senior Vice President of Clinical Strategy & Commercial Excellence at EBSCO Clinical Decisions, highlights that Dyna AI supports clinicians at the point of care by alleviating the burden of information search, and instead quickly surfacing the answers they need. "Since the release of Dyna AI for Dynamic Health and DynaMedex in July 2024, we have worked to communicate the important role that Dyna AI can play at the point of care. Dyna AI ensures that clinicians can get the evidence-based, expert-curated information they need quicker than ever before." Individual clinicians in the United States can experience Dyna AI with a free limited trial. Discover more about Dyna AI and how it can transform your clinical practice. About EBSCO Information Services EBSCO Information Services (EBSCO) is a leading provider of online research content and cutting-edge search technologies serving libraries, healthcare and medical institutions, corporations, and government agencies worldwide. As an AI-enabled services leader, EBSCO offers comprehensive solutions from research, acquisition management, subscription services and discovery services to clinical decision support and patient care, learning, and research and development, EBSCO provides institutions with access to content and resources to serve the information and workflow needs of their users and organizations. The EBSCO Clinical Decisions suite of products is designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. Our commitment to AI-driven innovation positions EBSCO at the forefront of the industry, enabling us to meet the evolving needs of the information services landscape. For more information, visit the EBSCO website at: Visit our blog at EBSCOpost or follow us on X, Facebook, LinkedIn and Instagram. For more information, please contact: Briana Peters Communications Specialist bpeters@ 978-414-0277 Media Contact Briana Peters, EBSCO Information Services, 978-414-0277, bpeters@ View original content: SOURCE EBSCO Information Services Sign in to access your portfolio
